IQE plc
("IQE" or the "Group")
IQE plc (AIM: IQE), the leading global supplier of advanced semiconductor
epitaxial wafer products and wafer services to the semiconductor industry, is
pleased to announce that NanoGaN Limited ("NanoGaN"), a wholly owned subsidiary
of IQE, has been granted two separate patents in relation to its nanocolumn
technology for the production of advanced blue and green lasers and LEDs.
Patent 2008-549935 has been granted by the Japan Patent Office to NanoGaN and
protects the Group's proprietary nanocolumn technology for producing high
quality, free-standing gallium nitride substrates, which are critical for
manufacturing high quality blue and green semiconductor lasers and ultra high
brightness LEDs for Solid State Lighting ("SSL").
A second patent, No.2446471, has been granted by the UK patent office to protect
the process for manufacturing semiconductor devices such as laser diodes, LEDs
and solar cells, directly onto the proprietary nanocolumn platform.
The production of advanced blue and green semiconductor lasers and ultra high
brightness LEDs requires stable, high quality substrates with minimal defects to
increase yield and therefore reduce manufacturing costs.
IQE acquired NanoGaN in October 2009 with the aim of assisting in completing the
development of commercial products and thereafter transferring the technology to
its high volume production facilities.
IQE's acquisition of NanoGaN complemented and enhanced IQE's product portfolio
by accelerating the Group's strategic plans to develop a leadership position in
the emerging high growth markets for advanced laser projection, high definition
optical storage (including Blue Ray products), high resolution laser printing
and SSL for industrial, commercial and residential lighting. It is envisaged
that NanoGaN's core technology may also be used to further enhance IQE's leading
position in the supply of GaN products for high power RF applications.
Dr. Drew Nelson, Group CEO and President said:
"Continuous innovation is one of IQE's key attributes that enables the Group to
offer its customers the broadest portfolio of leading edge semiconductor
technologies available.
"Adding these new patents to our existing portfolio, combined with strong
internal practices to protect intellectual property and know how, play a vital
role in ensuring IQE's position as a global leader in the manufacture and supply
of advanced semiconductor wafer products for the wireless, optoelectronic and
solar industry sectors."
Contacts:
IQE plc (+44 29 2083 9400)
Drew Nelson
Chris Meadows
Execution Noble & Company Limited (+44 20 7456 9191)
John Llewellyn-Lloyd
James Bromhead
College Hill (+44 20 7457 2020)
Adrian Duffield
Carl Franklin
[HUG#1435630]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: IQE plc via Thomson Reuters ONE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.